Amunix Pharmaceuticals, Inc.
ID: 6340523Amunix is an immuno-oncology company focused on developing immune-activating biotherapeutics for patients with solid tumor cancers.
4
Funding Rounds
$193.3m
Money raised
Recent Funding Rounds
Overview
Amunix is an immuno-oncology company focused on developing immune-activating biotherapeutics for patients with solid tumor cancers.
- Website:
- Business model: B2B
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Vo**** Sc************ |
|
- |
Industries
Amunix Pharmaceuticals, Inc. is active in the following industries: